Expression of survivin in ameloblastoma and its clinical significance

Abstract

Abstract: PURPOSE: To study the expression of survivin in ameloblastoma and its clinical significance. METHODS: Immunohistochemical S-P method was used to detect the expression of survivin in clinical significance. Seventy cases of ameloblastoma (AB), 15 cases of malignant AB and 30 cases of normal oral mucosa were included. SPLUS13.0 software package was used for statistical analysis. RESULTS: Survivin was strongly expressed in AB and malignant AB. The positive rate in malignant AB was up to 100%, followed by 82.9% in AB. Survivin was weakly expressed in normal oral mucosa, with a positive rate of 30%. The difference among the 3 groups was significant (P<0.05). CONCLUSIONS: Survivin is overexpressed in AB compared to normal oral mucosa. Survivin is involved in the development and progress of AB, and the ability of invasion and canceration of AB is correlated with the overexpression of survivin.

Key words: Ameloblastoma, Malignant ameloblastoma, Survivin

CLC Number:

R739.8

LI le, ZHANG Xing-le, WANG Peng, LIU Yu. Expression of survivin in ameloblastoma and its clinical significance[J]. Shanghai Journal of Stomatology, 2014, 23(4): 481-484.

References

[1] Ambrosini G, Adida C, Altieri DC, et al. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J]. Nat Med, 1997, 3(8): 917-921.
[2] 钟鸣, 张陆莊, 张波, 等. 人成釉细胞瘤中蛋白激酶C-α表达与端粒酶活性的关系[J]. 实用口腔医学杂志, 2006, 22(5): 696-699.
[3] Fine BA, Valente PT, Feinstein GI, et al. VEGF flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma [J]. Gynecol Oncol, 2000, 76(1): 33-39.
[4] Tamm I, Wang Y, Sausville E, et al . IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas(CD95), Bax, caspases, and anticancer drugs [J]. Cancer Res, 1998, 58(23): 5315-5320.
[5] Bria E, Visca P, Novelli F, et al. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer [J]. Eur J Surg Oncol, 2008, 34(5): 593-598 .
[6] Spaulding B, Pan D, Ghadersohi A, et al. Characterization of the 12C4 survivin monoclonal antibody and insight into the expression of survivin in human adult tissues [J] . Histopathology, 2006, 49(6): 622-633.
[7] Luo HY, Yu SF, Li TJ. Differential expression of apoptosis-related protein in various cellular components of ameloblastomas [J]. Int J Oral Maxillofac Surg, 2006, 35(8): 750-755.
[8] Kumamoto H, Ooya K. Detection of mitochondria-mediated apoptosis signaling molecules in ameloblastomas [J]. J Oral Pathol Med, 2005, 34(9): 565-572.
[9] Guzman JR , Fukuda S, Pelus LM. Inhibition of caspase-3 by Survivin prevents Weel kinase degradation and promotes cell survival by maintaining phosphorylation of p34Cdc2[J]. Gene Ther Mol Biol, 2009, 13B: 264-273.
[10] Khan S, Aspe JR, Asumen MG, et al. Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential[J]. Br J Cancer,2009,100(7): 1073-1086.